广场恐惧症治疗市场
广场恐惧症治疗市场：2026年市场规模约为25.1亿美元，2031年市场规模约为35.8亿美元；预测期复合年增长率为7.35%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
广场恐惧症治疗市场：2026年市场规模约为25.1亿美元，2031年市场规模约为35.8亿美元；预测期复合年增长率为7.35%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 7.35% | 机构预测 |
| 市场规模 | 2026 | USD 2.51 billion | 机构预测 |
| 市场规模 | 2031 | USD 3.58 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| care_setting | outpatient psychiatric clinics | 2025 | 82.340% |
| distribution_channel | hospital pharmacies | 2025 | 46.450% |
| geography | North America | 2025 | 40.450% |
| pharmacotherapy_class | SSRIs | 2025 | 58.760% |
| route_of_administration | oral therapies | 2025 | 84.340% |
| treatment_modality | pharmacotherapy | 2025 | 52.660% |
关键结论
- care_setting 维度中，outpatient psychiatric clinics 在 2025 年的公开份额为 82.34%。
- distribution_channel 维度中，hospital pharmacies 在 2025 年的公开份额为 46.45%。
- geography 维度中，North America 在 2025 年的公开份额为 40.45%。
- pharmacotherapy_class 维度中，SSRIs 在 2025 年的公开份额为 58.76%。
- route_of_administration 维度中，oral therapies 在 2025 年的公开份额为 84.34%。
- treatment_modality 维度中，pharmacotherapy 在 2025 年的公开份额为 52.66%。
主要参与者
- Eli Lilly and Company
- GlaxoSmithKline plc
- Novartis AG
- Pfizer Inc.
- AstraZeneca PLC
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Increasing diagnosis and treatment-seeking for agoraphobia and panic disorder | +1.500% | Global, with stronger gains in North America and Western Europe | Short term (≤ 2 years) |
| Greater awareness, screening, and earlier intervention | +0.600% | North America and Europe, with emerging adoption in Asia-Pacific | Medium term (2-4 years) |
| Guideline-supported adoption of CBT, exposure therapy, and SSRIs | +1.800% | Global, with strong relevance in Europe and North America | Medium term (2-4 years) |
| Digital CBT, telepsychiatry, and virtual reality exposure delivery | +1.400% | North America, Germany, and emerging Asia-Pacific markets | Medium term (2-4 years) |
| Homebound patient demand for care outside traditional clinics | +0.700% | Global, especially among patients with severe mobility limitations | Medium term (2-4 years) |
| Stepped-care outcomes tracking and personalized exposure pathways | +0.500% | North America and Europe, with limited adoption in Asia-Pacific | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Mental-health stigma and delayed presentation | -0.800% | Global, with particular relevance in Asia-Pacific | Long term (≥ 4 years) |
| Limited access, reimbursement gaps, and out-of-pocket burden | -0.900% | Asia-Pacific, Middle East and Africa, South America, and rural areas in North America and Europe | Medium term (2-4 years) |
| Shortage of therapists trained in graded exposure | -0.500% | Global, especially rural and lower-income areas | Long term (≥ 4 years) |
| Diagnostic heterogeneity and treatment-revenue attribution | -0.400% | Global | Medium term (2-4 years) |
报告关注的关键问题
What is the projected value of agoraphobia treatment by 2031?
The agoraphobia treatment sector is forecast to reach USD 3.58 billion by 2031, from USD 2.51 billion in 2026, at a CAGR of 7.35%.
Which treatment approach holds the largest revenue share?
Pharmacotherapy held 52.66% of revenue in 2025, supported by the established use of SSRIs and SNRIs.
Which therapy approach is expanding fastest?
Combination and Adjunctive Treatment is forecast to grow at an 8.15% CAGR through 2031.
Why are digital therapies important for agoraphobia care?
Digital cognitive behavioral therapy and virtual care can serve patients who struggle to travel to clinics because of avoidance symptoms.
Which region is growing fastest for agoraphobia treatment?
Asia-Pacific is forecast to expand at an 8.58% CAGR through 2031, supported by infrastructure investment and underdiagnosis correction.
What limits access to agoraphobia treatment?
Stigma, uneven reimbursement, out-of-pocket therapy costs, and shortages of trained therapists continue to limit treatment uptake.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence